Biosimulation Market Scenario
Growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems and increasing in the biologics and biosimilars markets are some of the major factors propelling the biosimulation market globally. Furthermore, need to curtail drug discovery and development costs is also one of the factor propelling the growth of biosimulation market. However, lack of standardization is one of the major factor expected to hamper the global growth of the market.
Biosimulation Market Segmentation
The Biosimulation market is segmented by Product & Service, Application, End User and Geography. The Product & Service studied in the report are Software (PK/PD Modeling and Simulation Software, Molecular Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Toxicity Prediction Software, Trial Design Software and Other Biosimulation Software) and Services (In-House Services and Contract Services). Furthermore, the Application comprises of Drug Development (Preclinical Testing and Clinical Trials), Drug Discovery (Target Identification and Validation and Lead Identification and Optimization) and Other Applications. Likewise, the End User includes Pharmaceutical & Biotechnology Companies, Research Institutes, Contract Research Organizations, Regulatory Authorities and Other End Users. Based on Geography, the Biosimulation market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Biosimulation Market by Geography
Based on geography, the Biosimulation market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global Biosimulation market. Major drivers include rising healthcare spending in the U.S., high number of off-patented drugs and rising demand for biosimilars in different therapeutic applications in this region is expected to support the growth of the market.
Biosimulation Market Key Players
Some of the major players operating in the global Biosimulation market includes Advanced Chemistry Development, Certara, Chemical Computing Group, Dassault Systèmes, Evidera, Genedata, In Silico Biosciences, Inosim Software, Insilico Biotechnology, Leadinvent Technologies, Nuventra Pharma, Physiomics, Rosa, Schrödinger and Simulation Plus. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market.
Biosimulation Market Report Key Benefits